What is Blackstone's stake sale in Mphasis?

Blackstone's promoter entity, BCP Topco IX Pte. Ltd., is set to sell up to a 9.5% stake in Mphasis through a block deal on Dalal Street.

Which other companies are seeing major stake sales?

Paytm and Emcure Pharma are also witnessing stake sales by promoters and private equity firms like Saif III Mauritius, SAIF Partners, Elevation Capital, and Bain Capital.

What is the total value of block deals expected on Dalal Street?

Block deals worth nearly ₹6,800 crore ($800 million) are expected to take place on Dalal Street on November 18, 2025.

Home / Business and Economy / Blackstone Sells 9.5% Stake in Mphasis in $800M Block Deal Spree

Blackstone Sells 9.5% Stake in Mphasis in $800M Block Deal Spree

18 Nov, 2025

•

Summary

Blackstone to sell 9.5% stake in Mphasis at ₹2,570 per share
Paytm, Emcure Pharma also see major stake sales by promoters, PE firms
Block deals worth nearly ₹6,800 crore expected on Dalal Street

Blackstone Sells 9.5% Stake in Mphasis in $800M Block Deal Spree

On November 18, 2025, Dalal Street is expected to witness a flurry of block deals worth nearly ₹6,800 crore ($800 million) as promoters and private equity firms look to cash out following the conclusion of the earnings season.

The biggest deal is set to be Blackstone's sale of up to a 9.5% stake in Mphasis, the IT services firm. Blackstone's promoter entity, BCP Topco IX Pte. Ltd., will sell the shares at a floor price of ₹2,570 per share, a 4.4% discount to the previous day's closing price. This transaction is expected to fetch around ₹4,626 crore.

Paytm is also seeing stake sales, with Saif III Mauritius, SAIF Partners, and Elevation Capital likely to offload up to 2% of the company's equity worth ₹1,640 crore. The floor price for this deal has been set at ₹1,281 per share, a 3.9% discount.